Cite
HARVARD Citation
Gettinger, S. et al. (n.d.). 3094 Nivolumab (NIVO) safety profile: Summary of findings from trials in patients (pts) with advanced squamous (SQ) non-small cell lung cancer (NSCLC). European journal of cancer. pp. S631-. [Online].